Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(7%)
Results Posted
25%(2 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_2
4
29%
Ph phase_3
1
7%
Ph phase_4
3
21%
Ph not_applicable
1
7%
Ph phase_1
3
21%

Phase Distribution

3

Early Stage

4

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
4(33.3%)
Phase 3Large-scale testing
1(8.3%)
Phase 4Post-market surveillance
3(25.0%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
unknown3
Withdrawn1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (25.0%)
Phase 24 (33.3%)
Phase 31 (8.3%)
Phase 43 (25.0%)
N/A1 (8.3%)

Trials by Status

withdrawn17%
completed857%
terminated17%
active_not_recruiting17%
unknown321%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT01659606Phase 2

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

Active Not Recruiting
NCT05692739Phase 4

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Completed
NCT03865888Phase 3

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

Completed
NCT03801746Phase 1

Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin

Completed
NCT03170323Phase 4

Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy

Unknown
NCT00282412Phase 1

Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism

Terminated
NCT02904772Phase 2

Alipogene Tiparvovec for the Treatment of LPLD Patients

Withdrawn
NCT01812954

Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis

Completed
NCT03218657Not Applicable

Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole

Unknown
NCT01014234Phase 2

Rapamycin and Regulatory T Cells in Kidney Transplantation

Completed
NCT01746823

Identification and Validation of Functional Biomarkers for Keratoconus

Unknown
NCT01079988Phase 4

Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence

Completed
NCT00983424Phase 1

Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer

Completed
NCT01068054Phase 2

Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14